| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $292.5M | +36.9% |
| Cost of Revenue | $85.6M | -44.2% |
| R&D Expense | $130.0M | -12.1% |
| SG&A Expense | $138.6M | -20.4% |
| Operating Income | -$80.8M | +69.6% |
| Pre-tax Income | -$94.2M | +66.7% |
| Income Tax | $0 | — |
| Net Income | -$94.2M | +66.7% |
| EPS (Basic) | -$0.52 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $90.5M | -39.6% |
| Accounts Receivable | $40.3M | -20.8% |
| Inventory | $21.6M | -43.5% |
| Current Assets | $185.2M | -31.9% |
| Total Assets | $356.1M | -32.3% |
| Current Liabilities | $129.5M | -49.5% |
| Long-term Debt | $66.1M | -32.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$73.2M | +71.1% |
| Capital Expenditures | $114K | +93.2% |
| Investing Cash Flow | -$114K | -100.3% |
| Financing Cash Flow | $14.6M | -89.1% |
| Free Cash Flow | -$73.3M | +71.0% |
| +69.4% |
| EPS (Diluted) | -$0.52 | +69.4% |
| Total Liabilities |
| $350.8M |
| -21.9% |
| Stockholders' Equity | $5.2M | -93.2% |